Apabetalone (RVX208)

apabetalone · Resverlogix Corp

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Apabetalone (RVX208), covering 2025-04-18 to 2025-04-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Apabetalone in Subjects With Long -COVID [Phase 2, Phase 3]